MMedication Read More GLP-1s for Addiction: Are We There Yet?July 3, 2026 Substance use disorders (SUDs) may become the next therapeutic target for GLP-1 receptor agonists (GLP-1s). Although the evidence…
HHealth Read More New Review Finds Creatine Shows Promise for Depression With Major CaveatsJuly 1, 2026 Credit: Pexels Creatine is among the most studied supplements in sports, with evidence that it can boost strength,…
HHealthcare Read More 3 Companies Redefining Healthcare InnovationJune 25, 2026 This article was originally published on ETFTrends.com. The Healthcare Technology and Innovation index (HTEC) was launched back in…
MMental health Read More Definium LSD therapy for major depression helped patients in Phase 3 trialJune 23, 2026 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
MMedication Read More Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with TacrolimusJune 22, 2026 Eledon Pharmaceuticals, Inc. Tegoprubart-treated patients maintained higher mean eGFR over time, including a statistically significant approximately 12 mL/min/1.73…
MMedication Read More The Drug That Bought My Father More Time Didn’t Happen by AccidentJune 19, 2026 I still remember the day my father and I sat in his oncologist’s office and first heard the…
HHealthcare Read More TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 TrialJune 10, 2026 TG Therapeutics, Inc. 82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement…
HHealth Read More AI-designed ‘universal vaccine’ candidate passes first human trialJune 5, 2026 Image: © Bill Oxford | iStock An innovative universal vaccine technology has successfully completed its first human clinical…
TTechnology Read More New York Valves 2026 To Unveil Late-Breaking Research in Structural Heart DiseaseJune 3, 2026 Newswise — NEW YORK – June 2, 2026 – The Cardiovascular Research Foundation® (CRF®) announced the highly anticipated…
HHealth Read More Lab Research Suggests Magnetic Particle Imaging May Help Researchers Find More Effective Ways to Deliver Cell TherapiesJune 2, 2026 Newswise — Scientists at Johns Hopkins Medicine say they used a form of magnetic imaging to track cell…
HHealth Read More Cancer trial shows promising results for treatment-resistant tumorsMay 31, 2026 Doctors on Saturday praised “unprecedentedly strong responses” to an injection that eradicated entire tumors in otherwise treatment-resistant cancer…
NNutrition Read More The Supplement That Science Says Could Make the World Less AngryMay 28, 2026 If you found out a supplement existed that could lower aggression, you would probably think it was something…